Study S002078

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies - a Pilot Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT05920889
Acronym: GALLOP
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 140
Start: 2023-08-01
Primary completion: 2024-10-25
Lead sponsor: Chinese University of Hong Kong
Conditions: Stroke; Stroke, Acute; Stroke, Ischemic; Brain Diseases
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change of Modified Rankin Score [Day 90]
Composite Safety Outcome [Day 90]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0002511	Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy-a phase 2 randomized trial. Wang H, Nature communications	2025	Randomized trial	PMID 41392086 DOI	cites ClinicalTrials.gov:NCT05920889; registry reference DERIVED:41392086